110299-94-0

Upstream product

• 1383381-34-7 6-isopropylidene-1-oxa-spiro[2.5]octane 
• 1383381-36-9 trifluoromethanesulfonic acid 4-isopropylidenecyclohex-1-enyl ester 
• 1383381-35-8 3,5-dinitrobenzoic acid 4-isopropylidene cyclohex-1-enylmethyl ester 
• 19620-35-0 8-(propan-2-ylidene)-1,4-dioxaspiro[4.5]decane 
• 19620-36-1 4-(propan-2-ylidene)cyclohexan-1-one 
• 4746-97-8 cyclohexanedione monoethylene ketal 

Downstream Products

• 1383381-39-2 isoperillyl chloroformate 
• 1383381-35-8 3,5-dinitrobenzoic acid 4-isopropylidene cyclohex-1-enylmethyl ester 
• 1383381-40-5 4-(3-(cyclopentyloxy-4-methoxyphenyl)-2-oxo-pyrrolidine-1-carboxylic acid 4-isopropylidenecyclohex-1-enylmethyl ester) 
• 1383381-38-1 (3-methyl 4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carbonyl)-carbamic acid-4-isopropylidene cyclohex-1-enylmethyl ester 
• 35931-84-1 4-isopropylidene-cyclohex-1-ene carbaldehyde 

Relevant academic research and scientific papers

Pharmaceutical Compositions Comprising Deuterium-Enriched Perillyl Alcohol, Iso-Perillyl Alcohol and Derivatives Thereof

The present invention, provides for a deuterium-enriched monoterpene or sesquiterpene such as perillyl alcohol, or a deuterium-enriched isomer or analog of monoterpenes or sesquiterpenes, such as isoperillyl alcohol. The present invention also provides for a deuterium-enriched derivative of a monoterpene or sesquiterpene, such as a perillyl alcohol carbamate or a deuterium-enriched derivative of an isomer or analog of a monoterpene or sesquiterpene, such as an isoperillyl alcohol carbamate. The deuterium-enriched derivative may be perillyl alcohol or isoperillyl alcohol conjugated with a therapeutic agent such as a chemotherapeutic agent. The present invention also provides for a method of treating a disease such as cancer, comprising the step of delivering to a patient a therapeutically effective amount of a deuterium-enriched compound.

METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL

The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of an isomer or analog of monoterpene or sesquiterpene (or its derivative), such as an i